BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld
BioWorld
March 19, 2002
View Archived Issues
Biovail Pays Solvay $94M For Hypertension Treatment
Read More
Armed T Cells Take On Mission Ambushing Tumor Cells, Guiding Killer Genes Into Lethal Position
Read More
AlgoRx Gets $25M In Series B, Buys PowderJect Technology
Read More
U.S. Patent Disclosures
Read More
Other News To Note
Read More
ViroPharma’s Picovir Goes Before FDA Panel; Analysts Divided
WASHINGTON In recent days, ViroPharma Inc. has been the subject of speculation surrounding the outcome of today’s government panel hearing on whether to recommend Picovir as a treatment for the common cold. (BioWorld Today)
Read More